Cancer

FDA grants priority review to Enhertu for breast cancer subset – Healio

January 18, 2022

The FDA granted priority review to fam-trastuzumab deruxtecan-nxki for treatment of certain patients with advanced breast cancer.

Read more

January 18, 2022
Show More

Related Articles

Photo of Lower Makefield corn hole event raises funds for cancer research – Bucks County Courier Times

Lower Makefield corn hole event raises funds for cancer research – Bucks County Courier Times

May 28, 2022

Boy Battling Cancer Becomes Honorary Police Officer | OCNJ Daily

May 28, 2022

High cost of cancer care in the US doesn't reduce mortality rates – ScienceDaily

May 28, 2022

Man with end-stage colon cancer seeks to share knowledge with fellow patients

May 27, 2022
Back to top button